Servier committed for better control & adherence of hypertensive and diabetic patients.
26/11/2024
21,400
employees in 149 countries
150
countries in which the Group’s medicines are distributed
20%
Over 20% of revenue from
brand-name medicines invested
in R&D each year
€ 4.9 billion
euros in revenue in 2021/2022 comprising €3,7 billion
for brand-name medicines and €1,2 billion
for generic medicines.
4 therapeutic areas
oncology, cardiometabolism, neuroscience
and immuno-inflammation
Servier Medical Art is a medical image bank that we make available to illustrate your medical releases.
OUR COMMITMENTS
At Servier, we believe that providing future generations with a healthier world is the very essence of our mission. As a leading pharmaceutical company, we work towards our purpose with passion, dedication, and determination.